Authors:
NEVITT MC
ETTINGER B
BLACK DM
STONE K
JAMAL SA
ENSRUD K
SEGAL M
GENANT HK
CUMMINGS SR
Citation: Mc. Nevitt et al., THE ASSOCIATION OF RADIOGRAPHICALLY DETECTED VERTEBRAL FRACTURES WITHBACK PAIN AND FUNCTION - A PROSPECTIVE-STUDY, Annals of internal medicine, 128(10), 1998, pp. 793
Authors:
FERESHETIAN AG
DAVIDSON M
HABER H
BLACK DM
Citation: Ag. Fereshetian et al., GEMFIBROZIL TREATMENT IN PATIENTS WITH ELEVATED LIPOPROTEIN A - A PILOT-STUDY, Clinical drug investigation, 16(1), 1998, pp. 1-7
Authors:
KOREN MJ
SMITH DG
HUNNINGHAKE DB
DAVIDSON MH
MCKENNEY JM
WEISS SR
SCHROTT HG
HENLEY RW
TRESH P
MCLAIN RW
BAKKERARKEMA RG
BLACK DM
Citation: Mj. Koren et al., THE COST OF REACHING NATIONAL-CHOLESTEROL-EDUCATION-PROGRAM (NCEP) GOALS IN HYPERCHOLESTEROLEMIC PATIENTS - A COMPARISON OF ATORVASTATIN, SIMVASTATIN, LOVASTATIN AND FLUVASTATIN, PharmacoEconomics, 14(1), 1998, pp. 59-70
Authors:
ZHAO JQ
HOARE SF
MCFARLANE R
MUIR S
PARKINSON EK
BLACK DM
KEITH WN
Citation: Jq. Zhao et al., CLONING AND CHARACTERIZATION OF HUMAN AND MOUSE TELOMERASE RNA GENE PROMOTER SEQUENCES, Oncogene, 16(10), 1998, pp. 1345-1350
Authors:
BAKKERARKEMA RG
BEST J
FAYYAD R
HEINONEN TM
MARAIS AD
NAWROCKI JW
BLACK DM
Citation: Rg. Bakkerarkema et al., A BRIEF PAPER OF THE EFFICACY AND SAFETY OF ATORVASTATIN IN EARLY CLINICAL-TRIALS, Perfusion, 11(2), 1998, pp. 79-86
Authors:
STONE K
BAUER DC
BLACK DM
SKLARIN P
ENSRUD KE
CUMMINGS SR
Citation: K. Stone et al., HORMONAL PREDICTORS OF BONE LOSS IN ELDERLY WOMEN - A PROSPECTIVE-STUDY, Journal of bone and mineral research, 13(7), 1998, pp. 1167-1174
Authors:
WOLFFENBUTTEL BHR
MAHLA G
MULLER D
PENTRUP A
BLACK DM
Citation: Bhr. Wolffenbuttel et al., EFFICACY AND SAFETY OF A NEW CHOLESTEROL-SYNTHESIS INHIBITOR, ATORVASTATIN, IN COMPARISON WITH SIMVASTATIN AND PRAVASTATIN, IN SUBJECTS WITH HYPERCHOLESTEROLEMIA, Netherlands journal of medicine, 52(4), 1998, pp. 131-137
Authors:
BLACK DM
BAKKERARKEMA R
HEINONEN T
NAWROCKI JW
Citation: Dm. Black et al., EFFICACY AND SAFETY OF ATORVASTATIN IN HYPERLIPIDEMIC PATIENTS WITH CONCURRENT HYPERTENSION OR NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Journal of hypertension, 16, 1998, pp. 31018-31018
Authors:
HUNNINGHAKE D
BAKKERARKEMA RG
WIGAND JP
DREHOBL M
SCHROTT H
EARLY JL
ABDALLAH P
MCBRIDE S
BLACK DM
Citation: D. Hunninghake et al., TREATING TO MEET NCEP-RECOMMENDED LDL CHOLESTEROL CONCENTRATIONS WITHATORVASTATIN, FLUVASTATIN, LOVASTATIN, OR SIMVASTATIN IN PATIENTS WITH RISK-FACTORS FOR CORONARY HEART-DISEASE, Journal of family practice, 47(5), 1998, pp. 349-356
Authors:
REEVES JR
HARRIS F
STANTON PD
GOING JJ
COOKE TG
BLACK DM
Citation: Jr. Reeves et al., PATIENT SURVIVAL IN SPORADIC BREAST-CANCER BY BRCA1 IMMUNOREACTIVITY IN CRYOSTAT SECTIONS USING ANTIBODIES MS110 AND MS13, Journal of pathology, 184, 1998, pp. 5-5
Authors:
PITT B
WATERS D
BROWN VW
MCCORMICK LS
WAGNER B
SHURZINSKE L
VANBOVEN AJ
BLACK DM
Citation: B. Pitt et al., RESULTS OF THE ATORVASTATIN VERSUS REVASCULARIZATION TREATMENTS (AVERT) STUDY - AN 18-MONTH STUDY OF AGGRESSIVE LIPID-LOWERING IN PATIENTS WITH STABLE CORONARY-ARTERY DISEASE INDICATED FOR A CATHETER-BASED REVASCULARIZATION (CR), Circulation, 98(17), 1998, pp. 3342-3342
Authors:
KEITH WN
ZHAO JQ
HOARE SF
MCFARLANE R
MUIR S
PARKINSON K
BLACK DM
Citation: Wn. Keith et al., CLONING AND CHARACTERIZATION OF HUMAN AND MOUSE TELOMERASE RNA GENE PROMOTER SEQUENCES, British Journal of Cancer, 78, 1998, pp. 62-62
Authors:
BLACK DM
THOMPSON DE
BAUER D
HOCHBERG M
ENSTUD K
MUSLINER TA
YATES AJ
CUMMINGS SR
Citation: Dm. Black et al., ANTIFRACTURE EFFICACY OF ALENDRONATE IN PATIENTS AT HIGH-RISK OF FRACTURE - RESULTS FROM THE FRACTURE INTERVENTION TRIAL, Arthritis and rheumatism, 41(9), 1998, pp. 577-577
Authors:
ENSRUD K
THOMPSON D
NEVITT M
HOCHBERG M
SANTORA A
BLACK DM
Citation: K. Ensrud et al., PREVALENT VERTEBRAL FRACTURES PREDICT HOSPITALIZATION AND MORTALITY IN OLDER WOMEN - THE FRACTURE INTERVENTION TRIAL (FIT), Arthritis and rheumatism, 41(9), 1998, pp. 1634-1634
Citation: Dm. Black et al., AN OVERVIEW OF THE CLINICAL SAFETY PROFILE OF ATORVASTATIN (LIPITOR),A NEW HMG-COA REDUCTASE INHIBITOR, Archives of internal medicine, 158(6), 1998, pp. 577-584
Authors:
MCKENNEY JM
MCCORMICK LS
WEISS S
KOREN M
KAFONEK S
BLACK DM
Citation: Jm. Mckenney et al., A RANDOMIZED TRIAL OF THE EFFECTS OF ATORVASTATIN AND NIACIN IN PATIENTS WITH COMBINED HYPERLIPIDEMIA OR ISOLATED HYPERTRIGLYCERIDEMIA, The American journal of medicine, 104(2), 1998, pp. 137-143
Authors:
BLACK DM
ORLOFF DG
BILHEIMER DW
SHEPHERD J
OLSSON AG
SACKS FM
PAOLETTI R
CATAPANO A
Citation: Dm. Black et al., SECTION III - SHOULD SEPARATE END-POINT TRIALS BE REQUIRED FOR ALL LIPID-LOWERING DRUGS ACTING BY THE SAME MECHANISM - SECTION III DISCUSSION, The American journal of cardiology, 81(8A), 1998, pp. 92-94
Authors:
HERRINGTON DM
FONG J
SEMPOS CT
BLACK DM
SCHROTT HG
RAUTAHARJU P
BACHORIK PS
BLUMENTHAL R
KHAN S
WENGER NK
Citation: Dm. Herrington et al., COMPARISON OF THE HEART AND ESTROGEN PROGESTIN REPLACEMENT STUDY (HERS) COHORT WITH WOMEN WITH CORONARY-DISEASE FROM THE NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEY III (NHANES-III)/, The American heart journal, 136(1), 1998, pp. 115-124
Authors:
SMITH DG
BAKKERARMEMA RG
MCLAIN RW
KOREN MJ
BLACK DM
Citation: Dg. Smith et al., THE COMPARATIVE EFFECTS OF ATORVASTATIN IN ACHIEVING DESIRED LIPID-LEVELS FOLLOWING NCEP GUIDELINES, American journal of managed care, 3(10), 1997, pp. 8-8
Authors:
SMITH DG
BAKKERARKMEMA RG
MCLAIN RW
BLACK DM
Citation: Dg. Smith et al., THE USE OF ADD-ON TREATMENT IN HMG-COA REDUCTASE INHIBITOR THERAPY TOACHIEVE TARGET LIPID-LEVELS, American journal of managed care, 3(10), 1997, pp. 9-9
Authors:
SMITH DG
BAKKERARKEMA RG
MCLAIN RW
BLACK DM
Citation: Dg. Smith et al., VARIATIONS IN COSTS AMONG PAYERS IN TREATMENT WITH HMG-COA REDUCTASE INHIBITOR THERAPY TO ACHIEVE TARGET LIPID-LEVELS, American journal of managed care, 3(10), 1997, pp. 10-10
Authors:
OOI TC
HEINONEN T
ALAUPOVIC P
DAVIGNON J
LEITER L
LUPIEN PJ
SNIDERMAN AD
TAN MH
TREMBLAY G
SORISKY A
SHURZINSKE L
BLACK DM
Citation: Tc. Ooi et al., EFFICACY AND SAFETY OF A NEW HYDROXYMETHYLGLUTARYL-COENZYME A REDUCTASE INHIBITOR, ATORVASTATIN, IN PATIENTS WITH COMBINED HYPERLIPIDEMIA -COMPARISON WITH FENOFIBRATE, Arteriosclerosis, thrombosis, and vascular biology, 17(9), 1997, pp. 1793-1799